39 results
6-K
EX-99.1
SNY
Sanofi
28 Jul 23
Solid Q2 performance and strong pipeline momentum
3:35pm
: Asian, Black, Hispanic.
Environment
Pilot take-back programs for insulin pens launched in 2 European countries
As part of Sanofi’s eco design
6-K
EX-99.2
SNY
Sanofi
28 Jul 23
Condensed Half-year Consolidated Financial Statements
7:00am
is Sanofi’s global initiative to rebuild trust in healthcare with the underrepresented, especially with Black and ethnic minority groups, women … target.
Inclusivity targets in the U.S. are defined by aligning with the demographics of the disease for the following communities: Asian, Black, Hispanic
6-K
EX-99.1
SNY
Sanofi
27 Apr 23
Strong Q1 growth driven by Specialty Care, Vaccines and CHC
11:39am
global initiative to rebuild trust in healthcare with the underrepresented, especially with Black and ethnic minority groups, women, people
6-K
EX-99.1
SNY
Sanofi
28 Jul 22
Strong execution in Q2 drives full-year 2022 guidance upgrade and delivers rich R&D news flow in Immunology and Rare Disease
10:12am
, Beacon of Hope began as a 10-year collaboration with Morehouse School of Medicine and 26 other Historically Black Colleges and Universities
6-K
EX-99.2
SNY
Sanofi
28 Jul 22
Condensed Half-year Consolidated Financial Statements
6:17am
, Beacon of Hope began as a 10-year collaboration with Morehouse School of Medicine and 26 other Historically Black Colleges and Universities
6-K
EX-99.3
2w2 uqobqa
15 Dec 21
Current report (foreign)
2:50pm
6-K
EX-99.2
ombl9sncbpr9 9l
26 Oct 21
Current report (foreign)
5:08pm
6-K
EX-99.2
uu0x930
10 Sep 21
Sanofi provides update on Phase 3 study evaluating rilzabrutinib for the treatment of pemphigus
3:23pm
6-K
EX-99.1
593phr7uk8d3wv lwj
29 Jul 21
Current report (foreign)
10:48am
6-K
EX-99.1
2uz2ec8j d7c8mc
4 Nov 20
Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products
3:27pm
6-K
EX-99.2
dnnajh4mike7p3rpxy4c
4 Nov 20
Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products
3:27pm
6-K
EX-99.2
tyo3wu 1xt
1 Oct 18
Sanofi completes divestiture of Zentiva to Advent
3:14pm